Skip to main content
. 2020 Sep 9;180(3):817–824. doi: 10.1007/s00431-020-03796-0

Table 4.

Clinical characteristics of the study population by EUGR in weight based on the Fenton charts

Non-EUGR
(n = 355)
EUGR
(n = 1,001)
p value
Gestational age (weeks) 26.6 ± 1.1 26.3 ± 1.0 < 0.001
Birthweight (grams) 880.2 ± 202.4 908 ± 184 0.017
Birthweight z score − 0.1 ± 1.0 0.3 ± 0.9 < 0.001
Male sex 175 (49.3) 526 (52.6) 0.294
Caesarean section 251 (70.7) 709 (70.8) 0.720
Maternal diabetes mellitus 30 (8.5) 67 (6.7) 0.281
Chorioamnionitis 133 (42.9) 392 (46.9) 0.231
PPROM 157 (44.7) 427 (43.0) 0.573
Oligohydramnios 44 (13.8) 107 (11.8) 0.372
Prenatal steroid 286 (81.7) 802 (81.6) 1.000
Multiple birth 112 (31.6) 292 (29.2) 0.418
Hypertension 56 (15.8) 87 (8.7) < 0.001
Apgar score 1 min 4.0 ± 1.9 3.9 ± 1.7 0.264
Apgar score 5 min 6.3 ± 1.8 6.3 ± 1.7 0.463
RDS 340 (95.8) 983 (98.2) 0.015
Treated PDA 170 (47.9) 610 (60.9) < 0.001
Moderate to severe BPD 170 (47.9) 464 (46.4) 0.621
IVH ≥ grade 3 19 (5.4) 122 (12.2) < 0.001
NEC 14 (3.9) 80 (8.0) 0.010
ROP ≥ stage 2 73 (20.6) 260 (26.0) 0.045
Sepsis 93 (26.2) 319 (31.9) 0.051
Duration of PN (days) 28.1 ± 16.9 38.6 ± 22.4 < 0.001
Length of stay (days) 91.4 ± 23.9 96.2 ± 24.0 0.001

Values are expressed as number (%) or mean ± standard deviation. EUGR, extrauterine growth restriction; PPROM, preterm premature rupture of membrane; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; BPD, bronchopulmonary dysplasia; IVH, intraventricular haemorrhage; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; PN, parenteral nutrition